课题基金 / 基金详情

NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS

NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS
抗艾滋病化合物的新型不对称合成
批准号:
3304404
负责人:
Joseph Paul Konopelski
金额:
$13.04万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-06-05 至 1994-05-31

项目摘要

项目成果

Joseph Paul Konopelski的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The principle objectives of the research program as set forth in this proposal are the development and execution of efficient asymmetric syntheses of the structural types found in the natural products castanospermine, deoxynojirimycin, and other glucosidase inhibitors, and oxetanocin, a novel oxetane-containing nucleosides with reverse transcriptase inhibitory activity. Members of these structurally distinct classes of compounds are being intensely scrutinized because of their anti- human immunodeficiency virus (HIV) activity. While we illustrate our strategy with syntheses of the natural compounds, our primary concern is with the definition of synthetic routes that are general enough so that the synthesis of analogs can be pursued directly, without the need to redesign the synthetic protocol for each new derivative. Thus, we expect that the generality of our synthetic approaches will allow for the facile production of new molecules structurally related to the target compounds (i.e., analogs), thereby enabling a better understanding of the relationship of chemical architecture and biological function. Certain analog syntheses are discussed in this proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
海外基金